News
The Commercial Launch of Rezipres®
Eton Pharmaceuticals and XGen Pharmaceuticals DJB Announce Commercial Launch of Rezipres® (ephedrine hydrochloride), a Ready-to-Use Formulation of Injectable Ephedrine (4.7 mg/mL) DEER PARK, Ill., March 14, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON) and XGen Pharmaceuticals DJB, Inc. today announced the commercial availability of Rezipres® (ephedrine hydrochloride) injection. Rezipres (4.7 mg/mL) is a [...]
read moreXGen Pharmaceuticals DJB Makes Multi-Million Dollar Essential Medicine Donation to Americares and Kingsway Charities
Big Flats, NY – December 1, 2020 XGen Pharmaceuticals DJB announced that they have made an essential medicine donation to Americares Foundation and Kingsway Charities valuing $2.5 million. These two organizations are global leaders in providing humanitarian aid around the world by way of Medical Missions, supporting namely the Armenia Artsakh Fund in Armenia and [...]
read moreEdmund (Ed) Vanderbeck joins XGen Pharmaceuticals DJB, Inc.
On May 4, 2020, Ed Vanderbeck joined XGen Pharmaceuticals DJB, Inc. as President, becoming only the third person to fill the position since the founding of Pharma-Tek almost 50 years ago. Ed joins XGen DJB as a proven pharmaceutical industry leader having spent the last twelve years of his career with Chemwerth, Inc., a full [...]
read moreThe Release of Folic Acid Injection, USP
XGen Pharmaceuticals DJB, Inc. announced today it will begin marketing and distributing Folic Acid Injection, USP. Folic Acid Injection, USP is a sterile non pyrogenic solution of sodium folate (prepared by the addition of sodium hydroxide to folic acid) in Water for Injection, USP intended for intramuscular (IM), intravenous (IV) or subcutaneous (SC) use. Folic [...]
read moreThe Relaunch of Ibuprofen Lysine
Big Flats NY - XGen Pharmaceuticals DJB Inc. announced today the relaunch of Ibuprofen Lysine injection. Ibprofen Lysine injection is therapeutically equivalent to Recordati Rare Diseases’ NeoProfen® Injection.Ibuprofen Lysine Injection is indicated to close a clinically significant patent ductus arteriosus (PDA), an abnormal opening between the aorta and the pulmonary artery. Ibuprofen Lysine treats premature infants [...]
read moreXGen Pharmaceuticals DJB, Inc. is closely monitoring the status of the COVID-19 outbreak.
XGen Pharmaceuticals DJB, Inc. is closely monitoring the status of the COVID-19 outbreak and its impact locally and globally. Due to the crucial role we play in providing pharmaceutical products to hospitals, and healthcare facilities throughout the supply chain, we are open and continue to operate with minimal staff to keep products going out to [...]
read moreThe Release of Dactinomycin for Injection, USP
Big Flats, NY., August 1st, 2019 – X-GEN Pharmaceuticals announced today the immediate availability in the United States of Dactinomycin for Injection, USP. Dactinomycin is an actinomycin indicated for the treatment of: • adult and pediatric patients with Wilms tumor, as part of a multi-phase, combination chemotherapy regimen. • adult and pediatric patients with rhabdomyosarcoma, [...]
read moreAmericares and X-GEN Improve Health in West Bank
(excerpt; full article below) "A vital donation from X-GEN Pharmaceuticals, has brought the people of Idhna the medicine they need. Americares and its in-country partner American Near East Refugee Aid (ANERA) recently delivered a shipment of nystatin, a topical powder used to treat skin infections. X-GEN’s donation has been crucial in combating dermatological conditions [...]
read moreX-GEN Pharmaceuticals Begins Marketing and Distributing Piperacillin and Tazobactam for Injection
Big Flats, NY, March 1, 2017 – X-GEN Pharmaceuticals announced today it will begin marketing and distributing Piperacillin and Tazobactam for Injection. X-GEN’s Piperacillin and Tazobactam for Injection is a combination penicillin-class antibacterial and β-lactamase inhibitor indicated for the treatment of various bacterial infections. The medical community has been plagued by shortages and inconsistencies in [...]
read moreAmeriCares and X-GEN Pharmaceuticals Support Underserved Patients in the Philippines
(excerpt; full article below) " Dedicated donors like X-GEN Pharmaceuticals, Inc. allow medical professionals in isolated and disadvantaged communities throughout the Philippines to address critical health issues in those who often have no other treatment options. Benefitting from X-GEN’s generous donation of Myambutol are patients like Nicol, a shoe-maker and resident of Bicol. Without the [...]
read moreOur website uses session cookies.
View our Privacy Policy.